Challenges and Opportunities in Detecting Critical Congenital Heart Disease in the Andes
Author Information
Author(s): Meza Kelly, Vasquez-Loarte Tania, Rodriguez-Alarcon J. Franco, San Roman Oscar, Rojas-Camayo Jose, Mejia Christian R., Medina Monica, Zapata Henry A., Saarinen Annamarie, Bravo-Jaimes Katia
Primary Institution: Universidad Nacional Mayor de San Marcos
Hypothesis
How can pulse oximetry screening be adapted for high-altitude populations to improve detection of critical congenital heart disease?
Conclusion
Adapting pulse oximetry screening protocols for high-altitude populations is essential to reduce the high mortality rates associated with critical congenital heart disease.
Supporting Evidence
- Approximately 54,000 children are born with congenital heart disease every year in Latin America.
- Only 17,000 of these children receive any treatment, leading to high mortality rates.
- Pulse oximetry screening has shown moderate sensitivity and high specificity in detecting critical congenital heart disease.
Takeaway
This study looks at how to better detect heart problems in babies born in the Andes mountains, where the air is thinner. It suggests changing the way we check their oxygen levels to help save more lives.
Methodology
The study reviews existing literature and data on congenital heart disease prevalence and screening effectiveness in high-altitude populations.
Potential Biases
Potential biases may arise from the variability in healthcare access and reporting practices across different countries in the Andes.
Limitations
The study highlights the lack of standardized screening protocols and the need for further research on cost-effectiveness in various Andean countries.
Participant Demographics
The study focuses on populations living at high altitudes in Andean countries, including Peru, Bolivia, and Colombia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website